Hyperinflammatory syndrome: Two viruses, similar story
No Thumbnail Available
Date
2023-01
Journal Title
Journal ISSN
Volume Title
Publisher
Chan Re Journals
Abstract
Objective: In countries where the co-existence of both dengue fever and COVID-19 infection is predominant, it is often difficult to clinically distinguish between the two entities. The present study highlights the similarities and differences between these viral diseases through two cases. Results: The first case was of a 38-year-old hypertensive and diabetic female, diagnosed with dengue hemorrhagic fever with leucopenia and thrombocytopenia (26000/mm3). HRCT chest revealed diffuse mosaic attenuation and small pleural effusion in both lower lobes. Elevation in D-dimer and deranged liver function test were noted. One-month follow-up revealed that she had persistent fever, fatigue, and musculoskeletal and psychological symptoms. Her symptoms improved with hydroxychloroquine 400 mg/day and a tapering course of steroids.The second case was of a 57-year-old hypertensive male, who presented with resolved mild COVID infection, blanching rash over the dorsal aspect of both hands with active synovitis around left wrist, elbow, and right ankle, and severe painful restriction of the joints. Positive COVID IgG, increased inflammatory parameters, and raised ferritin were noted. The patient showed symptomatic improvement with gradual reduction in inflammatory parameters following tapering dose of steroids and hydroxychloroquine treatment.Conclusion: Persistence of symptoms and increased inflammatory parameters were noted in both cases post viral clearance, suggesting a non-degenerative immune response, leading to collateral damage. The treating physicians should consider such a possibility and treatment with glucocorticoids in this scenario would be prudent.
Description
Keywords
hyperinflammatory, COVID, dengue.
Citation
Ramachandran Veena, S Chandrashekara, Kori Devaraj, J Prakruthi . Hyperinflammatory syndrome: Two viruses, similar story. Internet Journal of Rheumatology and Clinical Immunology. 2023 Dec; 11(1): 1-4